Cabenuva
(cabotegravir and rilpivirine)
Cabenuva is a 2-drug co-packaged product of cabotegravir, a HIV-1 integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI).
Podcast series
Welcome to "Cabenuva Conversations," a podcast series by ViiV Healthcare that brings you engaging discussions with healthcare providers (HCPs) from across the U.S. who have successfully integrated Cabenuva into their clinical practice. Join us as we explore their approaches in adopting Cabenuva and discover how these healthcare providers are making a positive impact for individuals living with HIV. Tune in to learn from their experiences and insights on advancing HIV care.
Episode 1: Implementation Experiences Utilizing Infusion Centers
Asia Sullivan, PA-C, MPH and Nikhil Bhayani, MD, FIDSA join us to discuss their experiences utilizing two different infusion centers models to implement Cabenuva.